Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.
Ichor Holdings (ICHR) is rated BUY, with fundamentals expected to improve in 2026 and a bottoming share price creating an attractive entry point. ICHR's new CEO is focused on operational discipline ...
If you are wondering whether BYD is still a smart buy after its big multiyear run, or if the easy money has already been made, you are not alone. That is exactly what this article will unpack. Despite ...
Wondering if Fastly is a hidden bargain or a value trap at around $10 a share? You are not alone. This is exactly the kind of stock where valuation really matters. Over the last week Fastly is up 4.2% ...
Venus in Sagittarius is angled towards Neptune, so relationships and connections feel dreamy. A lightness of energy will pervade the day ahead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results